Leah Gibson

Head of Investor Relations

Equibles does not estimate personal net worth.

About Leah Gibson

Leah Gibson is recorded as Head of Investor Relations at C4 Therapeutics, Inc. (CCCC). Leah Gibson has spoken on 1 investor event across 1 company, most recently for C4 Therapeutics, Inc. on June 18, 2026. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.

Leah Gibson on recent calls

“Good morning, and thank you for joining our educational webinar to discuss the multiple myeloma landscape, including the role of IKZF1 three-degraders in the emergent profile of simsidamide.”

Head of Investor Relations, Educational KOL Webinar on the Evolving Multiple Myeloma Treatment Landscape, the Role of IKZF1/3 Degradation and Cemsidomide’s Profile · June 18, 2026

Affiliation history

C4 Therapeutics, Inc. (CCCC)
Head of Investor Relations

Transcript header (unverified)

Current

Company network

C4 Therapeutics, Inc.

CCCC

Current role

Biotechnology · Healthcare

Head of Investor Relations

1 appearance Latest appearance 2026-06-18

View calls and events

Leadership on record at C4 Therapeutics, Inc.

Andrew J. Hirsch CEO
Andrew Phillips CEO
Ron Cooper Chairman, Board Member
Kendra R. Adams CFO, Chief Accounting Officer
Lauren White Chief Accounting Officer
Mark Mossler Chief Accounting Officer
William T. McKee Chief Accounting Officer
Adam S. Crystal Board Member
Donna Grogan, M.D. Board Member
Laura Bessen, M.D. Board Member

Recent activity

Investor Update Educational KOL Webinar on the Evolving Multiple Myeloma Treatment Landscape, the Role of IKZF1/3 Degradation and Cemsidomide’s Profile C4 Therapeutics, Inc. (CCCC)
2026-06-18